cyclopentane has been researched along with Chemical and Drug Induced Liver Injury in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, M; Farghali, H; Kutinova Canova, N; Njeka Wojnarova, L | 1 |
| Ademowo, OG; Farombi, EO; Kosoko, AM; Molokwu, CJ | 1 |
| Altman, JK; Bixby, DL; Blakemore, SJ; DeAngelo, DJ; Dezube, BJ; Erba, HP; Faessel, H; Giles, FJ; Hua, Z; Maris, M; Medeiros, BC; Sedarati, F; Swords, RT | 1 |
1 trial(s) available for cyclopentane and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study.
Topics: Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Cyclopentanes; Enzyme Inhibitors; Female; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Multiple Organ Failure; Myelodysplastic Syndromes; Pyrimidines; Ubiquitin-Activating Enzymes | 2015 |
2 other study(ies) available for cyclopentane and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
Differentiated modulation of signaling molecules AMPK and SIRT1 in experimentally drug-induced hepatocyte injury.
Topics: Acetaminophen; AMP-Activated Protein Kinases; Animals; Chemical and Drug Induced Liver Injury; Cyclopentanes; Hepatocytes; Rats; Sirtuin 1 | 2023 |
The protective effects of methyl jasmonate against adriamycin--induced hepatic and renal toxicities.
Topics: Acetates; Animals; Chemical and Drug Induced Liver Injury; Cyclopentanes; Dose-Response Relationship, Drug; Doxorubicin; Kidney; Kidney Diseases; Kidney Function Tests; Liver; Liver Function Tests; Mice; Mice, Inbred BALB C; Models, Animal; Oxylipins; Protective Agents; Treatment Outcome | 2012 |